Published in J Pediatr on March 01, 1998
Defects in activation and transport of fatty acids. J Inherit Metab Dis (1999) 0.87
Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment. J Inherit Metab Dis (1999) 0.77
Transcriptional Regulation of the Mitochondrial Citrate and Carnitine/Acylcarnitine Transporters: Two Genes Involved in Fatty Acid Biosynthesis and β-oxidation. Biology (Basel) (2013) 0.77
Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient. J Inherit Metab Dis (2004) 0.76
Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature. JIMD Rep (2015) 0.75
Dissecting the spectrum of fatty acid oxidation disorders. J Pediatr (1998) 0.75
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet (1999) 18.22
High-pressure liquid chromatography in polynucleotide synthesis. Biochemistry (1978) 5.98
Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37
Infants of very low birthweight. A 15-year analysis. Lancet (1979) 3.53
Common mistakes in infant feeding: survey from London borough. Br Med J (1978) 3.03
Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol (2001) 3.00
Genetic regulation of storaage protein content in maize endosperm. Biochem Genet (1976) 2.97
Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line. J Natl Cancer Inst (1995) 2.74
Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet (1991) 2.70
The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet (2002) 2.67
Small for dates babies: are they really a problem? Arch Dis Child (1986) 2.60
Structural basis of RNA folding and recognition in an AMP-RNA aptamer complex. Nature (1996) 2.51
Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet (1997) 2.45
Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child (1999) 2.39
Influence of loop residues on the relative stabilities of DNA hairpin structures. Proc Natl Acad Sci U S A (1988) 2.37
Leber hereditary optic neuropathy. J Med Genet (2002) 2.33
Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet (2001) 2.31
Somatic mitochondrial DNA mutations in adult-onset leukaemia. Leukemia (2003) 2.26
The pedigree rate of sequence divergence in the human mitochondrial genome: there is a difference between phylogenetic and pedigree rates. Am J Hum Genet (2003) 2.23
The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20
Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess (1997) 2.20
The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet (2000) 2.19
The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res (2001) 2.17
Influence of dangling thymidine residues on the stability and structure of two DNA duplexes. Biochemistry (1988) 2.16
Isolation and in vitro translation of zein messenger ribonucleic acid. Biochemistry (1976) 2.16
Breast feeding in an inner London borough--a study of cultural factors. Soc Sci Med (1977) 2.14
Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1998) 2.12
Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain (1997) 2.09
Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics (1996) 2.08
Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08
Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet (2006) 2.05
Thermodynamics and structure of a DNA tetraplex: a spectroscopic and calorimetric study of the tetramolecular complexes of d(TG3T) and d(TG3T2G3T). Proc Natl Acad Sci U S A (1992) 2.03
Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01
Quality assessment of urinary organic acid analysis. Ann Clin Biochem (1994) 1.90
Random genetic drift determines the level of mutant mtDNA in human primary oocytes. Am J Hum Genet (2000) 1.89
Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology (2006) 1.87
Repeated and continuous exposures of laboratory animals to trichlorofluoromethane. Toxicol Appl Pharmacol (1970) 1.87
Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child (1990) 1.86
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med (2008) 1.82
Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta (1998) 1.81
Comparative genomics and the evolution of human mitochondrial DNA: assessing the effects of selection. Am J Hum Genet (2004) 1.80
Mitochondrial gene segregation in mammals: is the bottleneck always narrow? Hum Genet (1992) 1.77
Peptide nucleic acid delivery to human mitochondria. Gene Ther (1999) 1.77
MELAS associated with mutations in the POLG1 gene. Neurology (2007) 1.77
Tetraplex formation of a guanine-containing nonameric DNA fragment. Science (1990) 1.75
An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol (1994) 1.74
Methylation of thymine residues during oligonucleotide synthesis. Nucleic Acids Res (1985) 1.74
Pancreatitis in patients with organic acidemias. J Pediatr (1994) 1.73
Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J (1977) 1.71
Cardiomyopathy in propionic acidaemia. Eur J Pediatr (1993) 1.70
Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care (1994) 1.68
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet (1997) 1.68
Calorimetric and spectroscopic investigation of the helix-to-coil transition of the self-complementary deoxyribonucleotide ATGCAT. Biophys Chem (1981) 1.67
Mitochondrial disease--its impact, etiology, and pathology. Curr Top Dev Biol (2007) 1.64
Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis (1999) 1.63
Thermodynamic comparison of the base pairs formed by the carcinogenic lesion O6-methylguanine with reference both to Watson-Crick pairs and to mismatched pairs. Biochemistry (1989) 1.60
Mitochondrial medicine. QJM (1997) 1.58
Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation (1999) 1.57
Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia. Lancet (1984) 1.55
Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet (1997) 1.53
The early detection and management of inborn errors presenting acutely in the neonatal period. Eur J Pediatr (1985) 1.53
Regional variations in medium-chain acyl-CoA dehydrogenase deficiency. Lancet (1995) 1.52
Analysis of European mtDNAs for recombination. Am J Hum Genet (2000) 1.51
Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion. J Inherit Metab Dis (2002) 1.51
Contribution of aminoacid catabolism to propionate production in methylmalonic acidaemia. Lancet (1989) 1.50
Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood. Arch Dis Child (1992) 1.49
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol (1999) 1.46
Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation (1986) 1.46
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol (1997) 1.45
Effects on experimental animals of long-term inhalation of trichloroethylene, carbon tetrachloride, 1,1,1-trichloroethane, dichlorodifluoromethane, and 1,1-dichloroethylene. Toxicol Appl Pharmacol (1967) 1.45
Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child (1998) 1.45
A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J Inherit Metab Dis (1990) 1.43
Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology (2003) 1.43
Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain (1995) 1.42
Synthesis and characterization of a set of four dodecadeoxyribonucleoside undecaphosphates containing O6-methylguanine opposite adenine, cytosine, guanine, and thymine. Biochemistry (1984) 1.42
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence. Mol Cell Biol (1991) 1.42
Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun (1992) 1.42
Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology (1994) 1.41
Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr (2000) 1.41
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest (1996) 1.40
Character of the glass transition in thin supported polymer films. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.40
Effects of physical activity and age on mitochondrial function. QJM (1996) 1.39
Biotinidase deficiency: early neurological presentation. Dev Med Child Neurol (1994) 1.39
Hypoglycaemia complicating feeding regimens for glycogen-storage disease. Lancet (1978) 1.39
Recurrent strokes in a 34-year-old man. Lancet (1997) 1.39
How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency? J Inherit Metab Dis (2004) 1.38
Melting behavior of a covalently closed, single-stranded, circular DNA. Biochemistry (1989) 1.37
Structural studies of the O6meG.C interaction in the d(C-G-C-G-A-A-T-T-C-O6meG-C-G) duplex. Biochemistry (1986) 1.36
Neurological implications of urea cycle disorders. J Inherit Metab Dis (2007) 1.36
Which drug for the adult epileptic patient: phenytoin or valproate? Br Med J (Clin Res Ed) (1985) 1.36
The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology (2010) 1.36
Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet (2004) 1.35
Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann Neurol (2000) 1.35
Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol (1993) 1.35
Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. Neurology (2009) 1.35
Carnitine palmitoyltransferase deficiencies. Mol Genet Metab (1999) 1.34
Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet (1997) 1.34